A randomised, double-blind, placebo-controlled crossover clinical trial on the effect of lactulose on improving the intestinal environment. - A clinical trial on the effect of lactulose on improving the intestinal environment.

Megurodoori Gastrointestinal Surgery Internal Medicine Clinic0 个研究点目标入组 36 人开始时间: 2021年5月20日最近更新: 2023年10月17日

适应症

试验速览

Ingestion of 4 g of lactulose for 3 days increased fecal bifidobacterial occupancy.

•1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases. 2) Subjects with the history of gastrointestinal resection. 3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4) Subjects who use medicines or supplements that may influence feces frequency; e.g. antibiotics, probiotics, laxatives, antidiarrheals, fibers. 5) Subjects with milk allergy or lactose intolerance. 6) Subjects who participate another study. 7) Subjects who are judged inappropriate for the study by the investigator or the physician.

发起方

Megurodoori Gastrointestinal Surgery Internal Medicine Clinic